Voglibose (0.2mg)
Voglive 0.2 mg Tablets are generally used for:
Voglive 0.2mg Tablet includes Voglibose, an alpha-glucosidase inhibitor that helps type 2 diabetics control their blood sugar levels. It is especially effective at reducing postprandial (after-meal) blood sugar rises. This medicine works by blocking the enzymes that break down carbohydrates into glucose, which slows glucose absorption. It is commonly used in combination with other antidiabetic drugs to improve glycemic control. Voglive should be taken exactly as prescribed by a healthcare physician, and blood sugar levels should be monitored on a regular basis.
The common negative effects of Voglive 0.2mg Tablet include:
If you experience severe or persistent side effects, see a doctor right away.
strip of 10 tablets
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take the medication orally, as directed by your doctor. Typically, it is consumed with the first mouthful of food. Avoid crushing, chewing, or breaking the tablet. Swallow it completely, with water. The dose and length are determined by your medical condition and reaction to treatment.
Voglibose, the active ingredient in Voglive 0.2mg Tablet, inhibits alpha-glucosidase. It operates as follows:
Related Warnings
Avoid or limit alcohol consumption while taking Voglive 0.2mg Tablet. Alcohol can cause blood sugar changes, resulting in either hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), which can impair the medication's effectiveness.
Voglive 0.2mg Tablet should not be used during pregnancy unless absolutely essential. There is minimal information on the safety of Voglibose during pregnancy. If you are pregnant or want to conceive, see your doctor before using this drug.
There is insufficient information on the usage of Voglibose when nursing. Before taking this drug while nursing, consult with a healthcare practitioner.
The ability to drive is usually unaffected by Voglive 0.2 mg Tablets. However, if you develop dizziness or confusion as a result of blood sugar variations, do not drive or operate heavy machinery.
If you have pre-existing kidney issues, exercise caution when taking Voglive 0.2mg Tablet. Dose changes may be required, as this medicine has the potential to worsen renal function in some individuals.
Patients with liver conditions should take Voglive 0.2mg Tablet with caution. It may impair liver function, necessitating regular monitoring of liver enzyme levels. If you have liver concerns, consult your doctor about optimal dosage and monitoring.
Q1. Can Voglive 0.2mg Tablet result in low blood sugar?
Voglive 0.2mg Tablet alone does not cause hypoglycemia (low blood sugar). However, when combined with other antidiabetic medications or insulin, it may raise the risk of hypoglycemia. Constantly check your blood sugar levels.
Q2. Is Voglive 0.2mg Tablet suitable for long-term use?
Yes, Voglive 0.2mg Tablet is generally considered safe for long-term usage when prescribed by a doctor. However, continuous monitoring of blood sugar, kidney, and liver function is required to avoid problems.
Q3. Can Voglive 0.2mg Tablet be taken with other diabetes medications?
Yes, Voglive 0.2mg Tablet can be used in conjunction with other antidiabetic drugs such as metformin, sulfonylureas, or insulin, as directed by your doctor.
Q4. What should I do if I miss a dosage of Voglive 0.2mg Tablet?
If you miss a dosage of Voglive 0.2mg Tablet, take it with your next meal. Do not increase the dose to compensate for a missed dose.
Q5. How long does it take Voglive 0.2mg Tablet to begin working?
Voglive 0.2mg Tablet begins to function after the first dose by limiting carbohydrate absorption after meals, hence lowering postprandial blood sugar levels.
